Familial Exudative Vitreoretinopathy.
Sızmaz S, Yonekawa Y, T Trese M.
Turk J Ophthalmol. 2015 Aug;45(4):164-168. doi: 10.4274/tjo.67699. Epub 2015 Aug 5.
Familial Exudative Vitreoretinopathy: Pathophysiology, Diagnosis, and Management.
Tauqeer Z, Yonekawa Y.
Asia Pac J Ophthalmol (Phila). 2018 May-Jun;7(3):176-182. doi: 10.22608/APO.201855. Epub 2018 Apr 9.
Ocular Features and Mutation Spectrum of Patients With Familial Exudative Vitreoretinopathy.
Tao T, Xu N, Li J, Li H, Qu J, Yin H, Liang J, Zhao M, Li X, Huang L.
Invest Ophthalmol Vis Sci. 2021 Dec 1;62(15):4. doi: 10.1167/iovs.62.15.4.
Familial Exudative Vitreoretinopathy-Related Disease-Causing Genes and Norrin/beta-Catenin Signal Pathway: Structure, Function, and Mutation Spectrums.
Xiao H, Tong Y, Zhu Y, Peng M.
J Ophthalmol. 2019 Nov 16;2019:5782536. doi: 10.1155/2019/5782536. eCollection 2019.
Familial Exudative Vitreoretinopathy (FEVR).
Luvisi JR, Blair K.
2025 Apr 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Familial exudative vitreoretinopathy and related retinopathies.
Gilmour DF.
Eye (Lond). 2015 Jan;29(1):1-14. doi: 10.1038/eye.2014.70. Epub 2014 Oct 17.
Familial exudative vitreoretinopathy.
Ebert EM, Mukai S.
Int Ophthalmol Clin. 1993 Spring;33(2):237-47. doi: 10.1097/00004397-199303320-00022.
Familial Exudative Vitreoretinopathy.
Chen KJ, Wang NK, Wu WC.
JAMA Ophthalmol. 2017 Apr 13;135(4):e165487. doi: 10.1001/jamaophthalmol.2016.5487. Epub 2017 Apr 13.
Familial exudative vitreoretinopathy.
Liche F, Majji AB.
Ophthalmology. 2012 May;119(5):1093. doi: 10.1016/j.ophtha.2012.02.025.
Familial Exudative Vitreoretinopathy With and Without Pathogenic Variants of Norrin/beta-Catenin Signaling Genes.
Kondo H, Tsukahara-Kawamura T, Matsushita I, Nagata T, Hayashi T, Nishina S, Higasa K, Uchio E, Kondo M, Sakamoto T, Kusaka S.
Ophthalmol Sci. 2024 Mar 15;4(5):100514. doi: 10.1016/j.xops.2024.100514. eCollection 2024 Sep-Oct.
